BREAKTHROUGH THERAPIES FOR SKIN DISEASES
Live / Registered — Registered (as of 07 Oct 2025)
What this means for you
Registered since 07 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98255148
- Registration number
- 7978294
- Mark type
- Stylized text
- Filed
- 04 Nov 2023
- Registered
- 07 Oct 2025
- Attorney of record
- Michael J. Hertz
Goods and services
- Class 042 — Scientific and technological services: Research and development of drugs and medicines for the treatment of infections, lung diseases, and skin diseases; Research and development in the pharmaceutical, life sciences, and biomedicine fields; Scientific research, testing, and analysis in the fields of pharmaceuticals, life science, and biomedicine; Medical and scientific research on lung diseases, skin diseases, infections, and cancer; Pharmaceutical products testing, analysis, research, and development
Owner
- Alphyn Biologics, Inc., Annapolis, MD, US
- Alphyn Biologics, Inc., Annapolis, MD, US
Prior registrations
Prosecution history
- 07 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Oct 2025 — REGISTERED-SUPPLEMENTAL REGISTER
- 03 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Sept 2025 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 11 Sept 2025 — USE AMENDMENT ACCEPTED
- 19 Aug 2025 — AMENDMENT TO USE PROCESSING COMPLETE
- 19 Aug 2025 — USE AMENDMENT FILED
- 19 Aug 2025 — TEAS AMENDMENT OF USE RECEIVED
- 19 Aug 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 19 May 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 19 May 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 19 Feb 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 19 Feb 2025 — FINAL REFUSAL E-MAILED
- 19 Feb 2025 — FINAL REFUSAL WRITTEN
- 11 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED